RAPT Therapeutics, Inc. — Director's Dealing 2021

Feb 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-02-11

Reporting Person: Robbins Wendye (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-11	Common Stock	G	300	—	Disposed	4800	Direct
2021-02-11	Common Stock	G	300	—	Acquired	300	Indirect

Footnotes

F1: This transaction involved a gift of securities by the reporting person to her daughter, who shares reporting person's household. The reporting person disclaims beneficial ownership of the shares held by her daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of her daughter's shares for purposes of Section 16 or for any other purpose.